JP2011523405A5 - - Google Patents

Download PDF

Info

Publication number
JP2011523405A5
JP2011523405A5 JP2011508703A JP2011508703A JP2011523405A5 JP 2011523405 A5 JP2011523405 A5 JP 2011523405A5 JP 2011508703 A JP2011508703 A JP 2011508703A JP 2011508703 A JP2011508703 A JP 2011508703A JP 2011523405 A5 JP2011523405 A5 JP 2011523405A5
Authority
JP
Japan
Prior art keywords
igf
variable domain
drug
immunoglobulin variable
chain immunoglobulin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2011508703A
Other languages
English (en)
Japanese (ja)
Other versions
JP5734180B2 (ja
JP2011523405A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2009/043273 external-priority patent/WO2009137758A2/en
Publication of JP2011523405A publication Critical patent/JP2011523405A/ja
Publication of JP2011523405A5 publication Critical patent/JP2011523405A5/ja
Application granted granted Critical
Publication of JP5734180B2 publication Critical patent/JP5734180B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2011508703A 2008-05-09 2009-05-08 Igf−ii/igf−iie結合タンパク質 Expired - Fee Related JP5734180B2 (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US5195608P 2008-05-09 2008-05-09
US61/051,956 2008-05-09
US5342708P 2008-05-15 2008-05-15
US61/053,427 2008-05-15
US16318009P 2009-03-25 2009-03-25
US61/163,180 2009-03-25
PCT/US2009/043273 WO2009137758A2 (en) 2008-05-09 2009-05-08 Igf-ii/gf-iie binding proteins

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2014016462A Division JP2014077020A (ja) 2008-05-09 2014-01-31 Igf−ii/igf−iie結合タンパク質

Publications (3)

Publication Number Publication Date
JP2011523405A JP2011523405A (ja) 2011-08-11
JP2011523405A5 true JP2011523405A5 (enExample) 2013-04-11
JP5734180B2 JP5734180B2 (ja) 2015-06-17

Family

ID=41265434

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2011508703A Expired - Fee Related JP5734180B2 (ja) 2008-05-09 2009-05-08 Igf−ii/igf−iie結合タンパク質
JP2014016462A Pending JP2014077020A (ja) 2008-05-09 2014-01-31 Igf−ii/igf−iie結合タンパク質

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2014016462A Pending JP2014077020A (ja) 2008-05-09 2014-01-31 Igf−ii/igf−iie結合タンパク質

Country Status (6)

Country Link
US (1) US20110165145A1 (enExample)
EP (1) EP2296703A4 (enExample)
JP (2) JP5734180B2 (enExample)
AU (1) AU2009244091B2 (enExample)
CA (1) CA2723722A1 (enExample)
WO (1) WO2009137758A2 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE20090368A1 (es) 2007-06-19 2009-04-28 Boehringer Ingelheim Int Anticuerpos anti-igf
EP2349329A4 (en) * 2008-10-14 2012-10-31 Dyax Corp USE OF IGF-II / IGF-II BINDING FOR THE TREATMENT AND PREVENTION OF SYSTEMIC SCLEROSIS ASSOCIATED WITH LUNG FIBROSIS
AR074726A1 (es) 2008-12-12 2011-02-09 Boehringer Ingelheim Int Anticuerpos anti-igf (factor de crecimiento insulinico)
US9150644B2 (en) 2011-04-12 2015-10-06 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Human monoclonal antibodies that bind insulin-like growth factor (IGF) I and II
US20140255413A1 (en) 2013-03-07 2014-09-11 Boehringer Ingelheim International Gmbh Combination therapy for neoplasia treatment
KR101843248B1 (ko) * 2015-03-17 2018-03-29 고려대학교 세종산학협력단 흉선 기질 림프단백질 매개 신호전달을 제어하는 펩타이드 유도체 및 이를 포함하는 알러지 및 천식 질환 예방 및 치료용 약학 조성물
US10469309B1 (en) * 2016-04-28 2019-11-05 Servicenow, Inc. Management of computing system alerts

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2058041A1 (en) 1990-06-27 1991-12-28 Katsuichi Sakano Anti-igf-ii monoclonal antibody
JP3213359B2 (ja) * 1990-12-21 2001-10-02 第一製薬株式会社 抗igf−iiモノクローナル抗体
WO2003093317A1 (en) * 2002-04-30 2003-11-13 Kyowa Hakko Kogyo Co., Ltd. Antibody to human insulin-like growth factor
US20060263362A1 (en) * 2003-08-21 2006-11-23 Atsushi Ochiai Cancer metastasis inhibitor
JPWO2005027970A1 (ja) * 2003-09-24 2007-11-15 協和醗酵工業株式会社 癌治療用医薬
US7498415B2 (en) * 2003-09-24 2009-03-03 Kyowa Hakko Kogyo Co., Ltd. Recombinant antibody against human insulin-like growth factor
US7612179B2 (en) * 2003-11-28 2009-11-03 Astrazeneca Ab antibodies binding to a C-terminal fragment of apoliopoprotein E
JP5054385B2 (ja) * 2004-02-19 2012-10-24 ダイアックス、コープ 立体配座特異的抗体
AU2005271523B2 (en) * 2004-08-03 2011-09-15 Dyax Corp. hk1-binding proteins
JP5149800B2 (ja) * 2005-08-17 2013-02-20 アメリカ合衆国 Igf−iiに特異的に結合するヒトモノクローナル抗体
DK1979001T3 (da) * 2005-12-13 2012-07-16 Medimmune Ltd Bindingsproteiner, der er specifikke for insulinlignende vækstfaktorer og anvendelser deraf
CN101578297A (zh) * 2006-04-07 2009-11-11 美国政府健康及人类服务部 治疗肿瘤疾病的抗体组合物和方法
US8178091B2 (en) * 2007-05-21 2012-05-15 University Of Washington Compositions and methods for the treatment of respiratory disorders

Similar Documents

Publication Publication Date Title
JP2011523405A5 (enExample)
JP2023061927A5 (enExample)
ES2585702T3 (es) Composiciones y métodos para la unión al ácido lisofosfatídico
TWI354561B (en) Pharmaceutical compositions and uses for treatment
JP2019523295A5 (enExample)
JP2004532817A5 (enExample)
TW201206478A (en) Multiple-variable dose regimen for treating TNF α -related disorders
JP2015508063A5 (enExample)
JP2019147801A5 (enExample)
Zandi et al. Introducing a protocol to create bisphosphonate-related osteonecrosis of the jaw in rat animal model
JP2012100677A5 (enExample)
JP2005533001A5 (enExample)
JP2010526028A5 (enExample)
JP2018529634A5 (enExample)
JP2018502120A5 (enExample)
RU2012156938A (ru) Антитела против gdf8 человека
JP2006522830A5 (enExample)
JP2006516116A5 (enExample)
JP2010500370A5 (enExample)
NO20083793L (no) Antistoffer mot amyloid-beta peptid
CN105358175B (zh) 用于治疗硬皮病的抗ccl2和抗loxl2组合疗法
JP2016509585A5 (enExample)
RU2014105496A (ru) Способы снижения числа эозинофилов
JP2022523740A (ja) Ror1抗体イムノコンジュゲートによる癌の治療
JP2009539841A5 (enExample)